Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Croda Sipo is a specialty chemical manufacturer that produces high-purity oleochemicals used as excipients and raw materials in the pharmaceutical and healthcare industries. Originally formed as a joint venture between Croda International and Sichuan Sipo Chemical, the company focuses on fatty acid derivatives and specialty esters. In 2022, the business was acquired by Cargill as part of Croda's divestment of its Performance Technologies and Industrial Chemicals division. The company's products are essential for drug formulation, providing stability and delivery solutions for various therapeutic applications. It operates a major manufacturing facility in Zigong, China, serving global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Croda Sipo.